AbbVie
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Illinois, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1 N Waukegan Rd, North Chicago, Illinois...Phone Number
(847) 932-7900Website
www.abbvie.comRevenue
$62.8 BillionStock Symbol
ABBVIndustry
ZI Rank: 3
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
48
2
5
4
5
3
About AbbVie
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.Explore more
AbbVie Org Chart
MR
Senior Financial Controller
FR
Controller
JC
Gulf-Levant Senior Financial Controller
SP
Financial Controller ( Abbvie , India)
FL
Financial Controller
GO
Controller
JF
Vice President, Commercial & Controller
YB
Controller
WM
Group Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AbbVie your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AbbVie, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at AbbVie
Click to see if AbbVie had a recent Job posting/layoffs
Check out if AbbVie is spiking on competitors!
Funding: Get notified immidiatlly once AbbVie has new funding data
Product Launch: Get notified when AbbVie launches new products
Earning: See what the market has to say on AbbVie recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if AbbVie has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at AbbVie
Find more new buyers
Compare Similar Companies to AbbVie
Compare insights from companies similar to AbbVie, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$72.2B
10K+
Public
-
1876
Hideyuki TozakiDirector, Research & Development & Chief Operating Officer, Oncology
$65.8B
10K+
Public
$20.9B
1891
AM
Allyson MunsellChief of Staff To the Senior Vice President, Global Communications
$48.5B
10K+
Public
$4B
1887
IC
Imara CharlesVice President, Chief of Staff, Global Product Development & Supply
Company Profile Activity
Activity Insights
AbbVie is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AbbVie is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AbbVie.
AbbVie Tech Stack
A closer look at the technologies used by AbbVie
Most Recent Scoops
Person-Based
Open Position
Open Position
Open Position
Open Position
AbbVie News & Media
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) The approval is supported by data from the Phase 3 Viti-Up clinical program, which showed that RINVOQ achieved statistically significant...Goldman Sachs uncovers key AbbVie stock signals before earnings
AbbVie(ABBV) reports second-quarter results on Friday, July 31, and the mood around the stock has changed. A few months ago, investors were restless. The two drugs carrying the company were doing fine, but everyone already knew that, and the market wanted a new reason to invest. Goldman Sachs went ...AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior systemic treatment regimens. As monotherapy, ELAHERE demonstrated a 37% reduction in the risk of disease progression or death versus prior standard chemotherapy, more than double the objective response rate aForget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck
A 2.8% Social Security raise barely covers a trip to the grocery store, so retirees are quietly rebuilding their paychecks around five dividend stocks with track records stretching back through every recession of the past two decades.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AbbVie
Sign Up For FreeTo access detailed company insights
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outc... Read More
